Oatman N, Gawali M, Congrove S, Caceres R, Sukumaran A, Gupta N
Cancer Res. 2024; 84(14):2333-2351.
PMID: 38885087
PMC: 11250569.
DOI: 10.1158/0008-5472.CAN-23-1635.
de Kort W, de Ruiter E, Haakma W, Driehuis E, Devriese L, van Es R
Head Neck Pathol. 2023; 17(3):697-707.
PMID: 37486536
PMC: 10514008.
DOI: 10.1007/s12105-023-01576-4.
Wagstaff W, Mwamba R, Grullon K, Armstrong M, Zhao P, Hendren-Santiago B
Genes Dis. 2022; 9(6):1608-1623.
PMID: 36157497
PMC: 9485270.
DOI: 10.1016/j.gendis.2022.04.004.
Zhang R, Neighbors J, Schell T, Hohl R
Oncoimmunology. 2022; 11(1):2104551.
PMID: 35936984
PMC: 9354771.
DOI: 10.1080/2162402X.2022.2104551.
Schmitt M, Sinnberg T, Niessner H, Forschner A, Garbe C, Macek B
Cancers (Basel). 2021; 13(21).
PMID: 34771574
PMC: 8582461.
DOI: 10.3390/cancers13215411.
Loss of miR-1469 expression mediates melanoma cell migration and invasion.
DiVincenzo M, Barricklow Z, Schwarz E, Moufawad M, Howard J, Yu L
PLoS One. 2021; 16(9):e0256629.
PMID: 34469478
PMC: 8409617.
DOI: 10.1371/journal.pone.0256629.
PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN.
Qin Y, Zuo Q, Huang L, Huang L, Merlino G, Yu Y
NPJ Precis Oncol. 2021; 5(1):68.
PMID: 34282258
PMC: 8289936.
DOI: 10.1038/s41698-021-00207-x.
Molecular mechanism of microRNA-26a regulation of phosphatase and tensin homolog gene in condyloma acuminatum and penile squamous cell carcinoma.
Hu Y, Hu E, Su X, Chen X, Tao X, Ren X
J Int Med Res. 2021; 49(7):3000605211014379.
PMID: 34232796
PMC: 8267046.
DOI: 10.1177/03000605211014379.
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications.
Vanni I, Tanda E, Dalmasso B, Pastorino L, Andreotti V, Bruno W
Front Mol Biosci. 2020; 7:172.
PMID: 32850962
PMC: 7396525.
DOI: 10.3389/fmolb.2020.00172.
Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.
Peters J, Kim D, Bility M, Borland M, Zhu B, Gonzalez F
Mol Carcinog. 2019; 58(9):1612-1622.
PMID: 31062422
PMC: 6692234.
DOI: 10.1002/mc.23033.
Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in Melanoma.
Giles K, Rosenbaum B, Berger M, Izsak A, Li Y, Illa Bochaca I
J Invest Dermatol. 2018; 139(2):430-438.
PMID: 30148988
PMC: 6342667.
DOI: 10.1016/j.jid.2018.07.031.
AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma.
Zuo Q, Liu J, Huang L, Qin Y, Hawley T, Seo C
Oncogene. 2018; 37(24):3275-3289.
PMID: 29551771
PMC: 6508599.
DOI: 10.1038/s41388-018-0205-4.
Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.
Fischer G, Gopal Y, McQuade J, Peng W, DeBerardinis R, Davies M
Pigment Cell Melanoma Res. 2017; 31(1):11-30.
PMID: 29049843
PMC: 5742019.
DOI: 10.1111/pcmr.12661.
Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinoma.
Gong Y, Yang H, Tian X
Exp Ther Med. 2017; 13(5):2544-2550.
PMID: 28565877
PMC: 5443281.
DOI: 10.3892/etm.2017.4264.
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.
Micevic G, Theodosakis N, Bosenberg M
Clin Epigenetics. 2017; 9:34.
PMID: 28396701
PMC: 5381063.
DOI: 10.1186/s13148-017-0332-8.
Active β-catenin is regulated by the PTEN/PI3 kinase pathway: a role for protein phosphatase PP2A.
Persad A, Venkateswaran G, Hao L, Garcia M, Yoon J, Sidhu J
Genes Cancer. 2017; 7(11-12):368-382.
PMID: 28191283
PMC: 5302038.
DOI: 10.18632/genesandcancer.128.
WNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner.
Brown K, Yang P, Salvador D, Kulikauskas R, Ruohola-Baker H, Robitaille A
Oncogene. 2017; 36(22):3119-3136.
PMID: 28092677
PMC: 5467017.
DOI: 10.1038/onc.2016.450.
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.
Pytel D, Gao Y, Mackiewicz K, Katlinskaya Y, Staschke K, Paredes M
PLoS Genet. 2016; 12(12):e1006518.
PMID: 27977682
PMC: 5207760.
DOI: 10.1371/journal.pgen.1006518.
Current State of Animal (Mouse) Modeling in Melanoma Research.
Kuzu O, Nguyen F, Noory M, Sharma A
Cancer Growth Metastasis. 2015; 8(Suppl 1):81-94.
PMID: 26483610
PMC: 4597587.
DOI: 10.4137/CGM.S21214.
RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma.
Laugier F, Finet-Benyair A, Andre J, Rachakonda P, Kumar R, Bensussan A
Oncotarget. 2015; 6(29):28120-31.
PMID: 26356562
PMC: 4695048.
DOI: 10.18632/oncotarget.4866.